Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors and cancer cell lines resistant to cisplatin, along with an experimental drug that targets that enzyme. The results were published on July…
Vaccine for Many Common Cold Viruses Achievable
T Cell Revival Through PD-1: Clues for Cancer Immunotherapy
Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients’ tumors do not respond to these drugs. Scientists from Emory Vaccine Center have now shown what molecular features distinguish the subset of T cells that wake…